Hypophosphatemic osteomalacia

Drug	Drug Name	Drug Description
DB01436	Alfacalcidol	A vitamin D analogue used for the management of hypocalcemia, secondary hyperparathyroidism, and osteodystrophy in patients with chronic renal failure, as well as some types of rickets and osteomalacia.

Drug	Drug Name	Target	Type
DB01436	Alfacalcidol	Vitamin D-binding protein	carrier
DB01436	Alfacalcidol	Vitamin D3 receptor	target
DB01436	Alfacalcidol	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	target
DB01436	Alfacalcidol	Retinoic acid receptor RXR-alpha	target
DB01436	Alfacalcidol	Alpha globin	carrier

Drug	Drug Name	Phase	Status	Count